Covid 19 95 These: Medicinal Lockout Part 2 - Ivermectin

Howdy all! We finish up the 2nd part of the Medicinal Lockout Episode.   

We're sticking with duplicity as the word of the day.   

As always, all data and studies are presented below!    

• https://www.sciencedaily.com/releases/2020/02/200206110703.htm  

 https://www.cnbc.com/2020/06/16/potential-coronavirus-treatment-dexamethasone-could-have-immediate-impact-former-fda-chief-says.html  https://www.usatoday.com/story/news/health/2020/07/22/covid-19-prednisone-linked-reduced-risk-coronavirus-death/5478793002/   

o https://www.msn.com/en-xl/news/other/doctors-warn-against-steroids-use-in-mild-covid-19-cases/ar-BB15PEin  

o https://www.cnn.ph/world/2021/3/5/ivermectin-not-effective-mild-covid.html  

o https://news.yahoo.com/hydroxychloroquine-ineffective-preventing-covid-19-trial-083950393.html

https://nationalinterest.org/blog/reboot/no-ivermectin-doesnt-cure-coronavirus-167135  

• https://c19ivermectin.com/   

• https://www.tga.gov.au/sites/default/files/auspar-ivermectin-151209.docx   

• https://trialsitenews.com/slovakia-becomes-the-first-eu-nation-to-formally-approve-ivermectin-for-both-prophylaxis-and-treatment-for-covid-19-patients/ 

• https://www.bloomberg.com/news/articles/2021-01-27/south-africa-allows-use-of-parasite-drug-to-treat-covid-patients 

• https://www.covid19treatmentguidelines.nih.gov/antiviral-therapy/ivermectin/ 

 https://trialsitenews.com/bird-evidence-to-decision-framework-meeting-for-ivermectins-efficacy/ 

• https://trialsitenews.com/randomized-double-blinded-clinical-trial-at-sheba-medical-center-ivermectin-materially-reduces-covid-19-viral-shedding/ 

• https://ejmo.org/10.14744/ejmo.2021.16263/ 

• https://timesofindia.indiatimes.com/city/noida/ivermectin-to-be-used-for-covid-treatment-in-up-to-replace-hcq/articleshow/77423417.cms 

o https://covid19criticalcare.com/wp-content/uploads/2020/11/FLCCC-Ivermectin-in-the-prophylaxis-and-treatment-of-COVID-19.pdf 

 https://aapsonline.org/aaps-applauds-nih-revised-stance-on-ivermectin-for-covid-19/